InterCure Stock

InterCure Forward P/E

The Forward P/E Ratio of InterCure (INCR.TA) as of Aug 5, 2026 is -2.25. In the previous year, Forward P/E Ratio was -2.47 — a change of -8.61% (higher).

Forward P/E

-2.25

YoY

-8.61%

Last updated:

Forward P/E Ratio of InterCure is 2026 -2.25 . Forward P/E Ratio of InterCure was 2025 -2.47 . It decreases by -8.61% higher compared to the previous year.
Access this data via the Eulerpool API

InterCure Stock analysis

What does InterCure do? InterCure Ltd. is a global company in the medical technology industry that focuses on the development, production, and distribution of innovative solutions for the diagnosis and treatment of chronic diseases. The company was founded in Israel in 2000 and is headquartered in Lod. InterCure is one of the most popular companies on Eulerpool.

Frequently Asked Questions about InterCure stock

Forward P/E Ratio of InterCure is -2.25 in 2026.

Forward P/E Ratio of InterCure changed from -2.47 to -2.25, representing a -8.61% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio InterCure since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's InterCure with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — InterCure

All Key Metrics — InterCure